Christopher Lanigan
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 5
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Carol Farver (3 shared papers)Sanjay Mukhopadhyay (2 shared papers)Raymond R. Tubbs (14 shared papers)Eugen C. Minca (11 shared papers)Josephine K. Dermawan (1 shared paper)Bryce P. Portier (7 shared papers)C. Patrick (4 shared papers)Nathan A. Pennell (3 shared papers)
- Journals
- American Journal of Clinical Pathology (4 papers)Journal of Thoracic Oncology (3 papers)Journal of Clinical Oncology (3 papers)Journal of Cutaneous Pathology (2 papers)Oncotarget (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Christopher Lanigan
26 papers receiving 564 citations
Peers
Comparison fields: 5 of 53
- Oncology 248
- Pulmonary and Respiratory Medicine 208
- Cancer Research 83
- Pathology and Forensic Medicine 93
- Neurology 58
Countries citing papers authored by Christopher Lanigan
This map shows the geographic impact of Christopher Lanigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Lanigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Lanigan more than expected).
Fields of papers citing papers by Christopher Lanigan
This network shows the impact of papers produced by Christopher Lanigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Lanigan. The network helps show where Christopher Lanigan may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Lanigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 103 | |
| 2 | 2013 | 95 | |
| 3 | 2020 | 47 | |
| 4 | 2018 | 45 | |
| 5 | 2014 | 44 | |
| 6 | 2013 | 30 | |
| 7 | 2014 | 28 | |
| 8 | 2017 | 25 | |
| 9 | 1989 | 22 | |
| 10 | 2013 | 21 | |
| 11 | 2020 | 18 | |
| 12 | 2015 | 13 | |
| 13 | 2013 | 11 | |
| 14 | 2013 | 11 | |
| 15 | 2015 | 11 | |
| 16 | 2015 | 10 | |
| 17 | 2014 | 10 | |
| 18 | 2013 | 8 | |
| 19 | 2014 | 7 | |
| 20 | 2016 | 6 |
About Christopher Lanigan
Christopher Lanigan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 27 papers that have together received 580 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Sarcoma Diagnosis and Treatment (3 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Research Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (248 citations), Pulmonary and Respiratory Medicine (208 citations), Cancer Research (83 citations), Pathology and Forensic Medicine (93 citations) and Neurology (58 citations). Christopher Lanigan has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Carol Farver, Sanjay Mukhopadhyay, Raymond R. Tubbs, Eugen C. Minca, Josephine K. Dermawan, Bryce P. Portier, C. Patrick, Nathan A. Pennell, Yan Feng and Daniela Allende. Their work appears in journals such as American Journal of Clinical Pathology, Journal of Thoracic Oncology, Journal of Clinical Oncology, Journal of Cutaneous Pathology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.